Court of Appeal orders increased monitoring when adolescent cannot receive irreversible hormone therapy Aitrend

Court of Appeal orders increased monitoring when adolescent cannot receive irreversible hormone therapy

 Aitrend

The Court of Appeal has ruled that further examination must be carried out before a 16-year-old child can receive private gender treatment. The decision states that the child can only have sex hormone treatment under careful judicial and NHS supervision. This case marks a significant shift in how courts view medical interventions for young people … Read more

Ozempic linked to risk of rare irreversible vision loss after large-scale trial Aitrend

Ozempic linked to risk of rare irreversible vision loss after large-scale trial

 Aitrend

A new study has found that diabetes patients using Ozempic have more than twice the risk of developing a rare form of vision loss compared to those taking other diabetes medications. The research, which examined patient records from Denmark and Norway, links the blockbuster drug to an increased risk of NAION, a disease affecting the … Read more